Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Feb. 28, 2017
Feb. 29, 2016
Statement of Cash Flows [Abstract]    
Net income (loss) $ 486,923 $ (122,936)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 57,634 74,618
Compensatory element of stock options 77,357 252,313
Provision for doubtful accounts 101,930 192,045
Amortization of debt issuance costs 34,153  
Changes in assets and liabilities:    
Accounts receivable (498,713) (350,656)
Prepaid expenses (64,451) (1,490)
Inventory 75,181 (22,916)
Other current assets (64,429) 30,051
Deposits and other assets, net (3,388)  
Accounts payable 34,721 357,156
Accrued expenses (439,668) (438,675)
Deferred revenue 631,809 131,907
Net cash provided by operating activities 429,059 101,417
Cash flows from investing activities:    
Release of restricted cash held in escrow   (56)
Purchases of property and equipment (2,921) (30,723)
Sales (purchases) of marketable securities and other investments, net 136,446 (157,238)
Net cash provided by (used in) investing activities 133,525 (188,017)
Cash flows from financing activities:    
Treasury stock purchases (88,691) (408,403)
Repayments of note payable (500,000) (75,423)
Proceeds from the exercise of stock options 33,496  
Net cash used in financing activities (555,195) (483,826)
Increase (decrease) in cash and cash equivalents 7,389 (570,426)
Cash and cash equivalents - beginning of period 3,499,881 4,152,162
Cash and cash equivalents - end of period 3,507,270 3,581,736
Supplemental non-cash investing activities:    
Unrealized loss on marketable securities, net of tax $ (7,061) $ (93,727)